Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Capital/Financing Update 2011

Mar 22, 2011

65640_rns_2011-03-22_8aca2cb8-dc11-4e6f-95ca-3752fbb65c79.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

MARKET RELEASE

23 March 2011

Phylogica Limited

TRADING HALT

The securities of Phylogica Limited (the "Company") will be placed in pre-open at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in pre-open until the earlier of the commencement of normal trading on Friday, 25 March 2011 or when the announcement is released to the market.

Security Code:

PYC. PYCO

of Heiner

Jill Hewitt Senior Adviser Listings (Perth)

BEYOND ANTIBODIES

23 March 2011

Ms Tonia Oliveira Issuers Adviser Australian Securities Exchange Exchange Plaza 2 The Esplanade PERTH WA 6000

By Facsimile: 9221 2020

Dear Tonia

Trading Halt

Phylogica Limited ("Phylogica" or "the Company") (ASX Code: PYC) requests an immediate trading halt be placed on its securities pending an announcement.

The company requests this trading halt whilst the company finalises a capital raising.

The company is undertaking the capital raising for working capital, purchase new capital equipment & product development.

Phylogica can see no reason why a trading halt should not be put on its securities. The Company's securities are to remain in the trading halt until the earlier of the commencement of normal trading on 25 March 2011 or when the announcement is released to the market.

If an announcement is not made at the end of the trading halt period, the Company will request a voluntary suspension of its securities.

Regards

ti dhe

Mr Gregory MacMillan Company Secretary